Butyrylcholinesterase deficiency: Clinical Trials

13 trials for Butyrylcholinesterase deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 recruiting, 2 unknown. 4 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Recruiting 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Butyrylcholinesterase deficiency: new trials by email Literature Review of Butyrylcholinesterase deficiency trials Research Report on Butyrylcholinesterase deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab
blood test - Diabete Mellitus, Retina Vein Occlusion
RecruitingAtaturk University1802025-11-032026-04-24
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Propofol, Rocuronium - Kidney Failure, Acute, Myopathy; Drugs
Not applicableRecruiting4th Military Clinical Hospital with Polyclinic, Poland322024-08-012024-11-27
High Flow Oxygen During Operative Hysteroscopy.
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)., LMA - Endometrium; Hypertrophy, Cervix, Anesthesia
Not applicableCompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS1802022-06-172024-09-05
Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases
Butyrylcholinesterase - Colorectal Disorders, Colorectal Neoplasms
CompletedUniversity Hospital of Patras4002019-11-062023-06-15
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)
optiflow - Apnea, Postanesthetic, Desaturation of Blood
Not applicableCompletedUniversity Hospital, Caen802019-04-232022-02-18
Race-Specific Propofol Titration to Effect for Procedural Sedation
Titrate propofol monotherapy infusion to effect - Unconsciousness, Apnea, Postanesthetic
CompletedUniversity of Florida27802018-01-052019-10-25
Comparison on Succinylcholine Onset Time Assessed by Train of Four Stimulation Versus Clinical Judgment During Rapid Sequence Induction of Anesthesia
Suxamethonium Sensitivity, Aspiration of Gastric Contents Into Respiratory Tract, Part Unspecified
UnknownUniversity Hospital, Caen1102017-11-062018-03-16
Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma
Trauma, Burns
CompletedUniversity Hospital Heidelberg852016-02-012019-04-16
Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Rivastigmine - Alzheimer's Disease
Not applicableUnknownSeoul National University Hospital702014-02-012015-05-14
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Huperzine A, Donepezil, Galantamine - Biomarkers, Pharmacological
CompletedU.S. Army Medical Research and Development Command842012-02-012017-05-03
Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
AZD8848 - Butyrylcholinesterase Deficiency
Phase 1CompletedAstraZeneca222010-09-012015-08-14
Use of Donepezil for Treatment of Cocaine Dependence
Donepezil, 5 mg daily, Oral Placebo - Cocaine Abuse and Dependence
Phase 2CompletedUS Department of Veterans Affairs122007-02-012014-06-09
A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine) - Lewy Body Disease
CompletedSunnybrook Health Sciences Centre572006-09-012016-04-13

Narrower conditions

Pain (3)  ·  Acute Kidney Injury (1)  ·  Alzheimer Disease (1)  ·  Apnea (1)  ·  Arrhythmias, Cardiac (1)  ·  Burns (1)  ·  Chronic Pain (1)  ·  Cocaine-Related Disorders (1)  ·  Colorectal Neoplasms (1)  ·  Congenital Abnormalities (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Retinopathy (1)  ·  Hypertrophy (1)  ·  Hypoxia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (6)  ·  Neurologic Manifestations (5)  ·  Nervous System Diseases (4)  ·  Mental Disorders (3)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Chemically-Induced Disorders (2)  ·  Dementia (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Signs and Symptoms, Respiratory (2)  ·  Basal Ganglia Diseases (1)  ·  Colonic Diseases (1)

Interventions

Donepezil (3)  ·  Galantamine (2)  ·  Rivastigmine (2)  ·  AZD8848 (1)  ·  Anesthesia, General (1)  ·  Butyrylcholinesterase (1)  ·  Cholinesterase Inhibitors (1)  ·  Hematologic Tests (1)  ·  Propofol (1)  ·  Rocuronium (1)  ·  Tobacco Use Cessation Devices (1)  ·  huperzine A (1)

Sponsors

University Hospital, Caen (2)  ·  4th Military Clinical Hospital with Polyclinic, Poland (1)  ·  AstraZeneca (1)  ·  Ataturk University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Seoul National University Hospital (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  U.S. Army Medical Research and Development Command (1)  ·  US Department of Veterans Affairs (1)  ·  University Hospital Heidelberg (1)  ·  University Hospital of Patras (1)  ·  University of Florida (1)

Countries

United States (3)  ·  France (2)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Poland (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Boutros Mariam (1)  ·  Eleonore Mulac-Vauclair (1)  ·  Jeffrey White, MD (1)  ·  Jesper Sonne, MD (1)  ·  Kamga Herve (1)  ·  Kenneth Grasing, MD (1)  ·  Marek Szamborski, MD (1)  ·  Pierre-Emmanuel Marsan (1)  ·  Sam Lindgren, MD, PhD (1)  ·  Stefan Hofer, Prof. Dr. (1)  ·  Stefan Kleinschmidt, Prof. Dr. (1)

Results publications

PMID 13630833, PMID 19836169, PMID 20406507, PMID 23737548, PMID 25388828, PMID 25869405, PMID 26329355, PMID 27856714, PMID 27879385, PMID 28320364, PMID 28403407, PMID 29743098, PMID 30767199, PMID 31401603, PMID 31584919, PMID 32398433, PMID 32882605, PMID 32890016, PMID 35371356, PMID 40690380, PMID 6808323, PMID 7429910

NIH funding

UL1TR001427 (1)